Sprintec Kit
Product Images NDC 63187-911

6 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sprintec (NDC 63187-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norgestimate Structural Formula (Image 01)

Norgestimate Structural Formula (Image 01)
Chemical structure of Norgestimate, the active ingredient in Sprintec, shown as a detailed molecular diagram with labeled atoms and bonds.*
FDA Label Image

Ethinyl Estradiol Structural Formula (Image 02)

Ethinyl Estradiol Structural Formula (Image 02)
Chemical structure of Ethinyl Estradiol, showing its molecular framework including hydroxyl groups and the ethinyl substituent, as part of the active ingredients in Sprintec.*
FDA Label Image

Fewer-more Pregnancies Image (Image 03)

Fewer-more Pregnancies Image (Image 03)
An illustration diagram showing contraceptive methods arranged vertically by their effectiveness, from fewer pregnancies to more pregnancies per 100 women per year. Methods include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*
FDA Label Image

Blister Image (Image 04)

Blister Image (Image 04)
Sprintec (norgestimate and ethinyl estradiol) 0.250 mg/0.035 mg tablet kit label showing a 28-day pill pack layout. The chart is organized by week and day with circles representing daily tablets, illustrating colored pills for the first three weeks and white tablets for the fourth week. Instructions advise taking all colored pills before any white pills. Storage conditions are noted at 20° to 25°C (68° to 77°F). The labeler is Proficient Rx LP.*
FDA Label Image

Blister Image (Image 05)

Blister Image (Image 05)
Sprintec 0.250 mg/0.035 mg oral tablets kit containing norgestimate and ethinyl estradiol. The image shows a 28-day pill pack with days of the week labeled from Sunday to Saturday, arranged in four weekly rows, with the fourth week tablets in a different color. The label includes storage instructions between 20° to 25°C (68° to 77°F) and directs users to take all colored pills before white pills.*
FDA Label Image

63187-911-28 (Image 06)

63187-911-28 (Image 06)
Sprintec 0.25mg/0.035mg kit label showing a 28-day supply with 28 tablets. The product is manufactured by Teva Pharmaceuticals USA, Inc., North Wales, PA. The label includes barcodes, NDC number 63187-911-28, storage instructions at 20°-25°C, and a caution to keep medication out of reach of children. The labeler is Proficient Rx LP, Thousand Oaks, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.